Technetium ⁹⁹ᵐTc oxidronic acid

Molecular mass: 290.906 g/mol  PubChem compound: 123801

Active ingredient description

Technetium ⁹⁹ᵐTc oxidronic acid is a radiopharmaceutical agent. A radiopharmaceutical is defined as a medicinal formulation containing radioisotopes that are used in major clinical areas for diagnosis and/or therapy. Technetium ⁹⁹ᵐTc oxidronic acid is indicated as a skeletal imaging agent in adults and children to delineate areas of abnormal osteogenesis, such as those that occur with metastatic bone disease, Paget’s disease, arthritic disease, osteomyelitis, and fractures.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
V09BA01 Technetium (99mTc) oxidronic acid V Various → V09 Diagnostic radiopharmaceuticals → V09B Skeleton → V09BA Technetium (99mTc) compounds
Discover more medicines within V09BA01

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
TECHNESCAN HDP Powder for solution FDA, National Drug Code (US) MPI, US: SPL/Old

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 72945-61-0
DrugBank Drug: DB09139
KEGG Drug: D06041
PubChem Compound: 123801
UNII Identifier: MG4KI49HHJ
TECHNETIUM TC-99M OXIDRONATE

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.